Refined Imaging, Inc.

First in the US, a NIH sponsored, uniquely designed, early-stage COPD diagnostic lung imaging instrument.

Facebook Twitter LinkedIn

Refined Imaging, Inc. (RI) is a Baton Rouge, Louisiana diversified imaging company specializing in x-ray interferometry, which is globally recognized as the best imaging technique to view small details in metals, polymers or humans.

The National Institute of Health (NIH) provided a grant to RI which allowed for the design of a lung imaging device that is fast, quantitative, and more sensitive to early-stage lung disease than a subjective pulmonary function test (PFT). X-ray interferometry lung imaging is far superior to radiography, CT or hyperpolarized MRI. This grant allowed RI to image 20 patients in a pilot study in Pennington Biomedical Research Center.

NIH also issued a grant to RI to perform a national marketing analysis to determine if the technology was wanted, needed and was willing to pay for it. The overwhelming conclusion was yes. This technology has been thoroughly vetted through a 500-patient COPD clinical trial illustrating that the technology works.


Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request